Tm Extends Alliance With Luminex to Sell Dx Products On xMAP Platform

Mar 29, 2006

NEW YORK, March 29 (GenomeWeb News) - Tm Bioscience has extended for multiple additional years an agreement with Luminex to sell DNA-based molecular diagnostics that operate on Luminex's xMAP platform, Tm said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

OpGen Increases Public Offering to up to $15.6M
Enzo Patent Found Invalid in Ongoing IP Lawsuits
Sciex Receives China FDA Approval for Mass Spec System
Hologic Receives CE Mark for Panther System Upgrade, Flu and Respiratory Assays
Rare Gut Condition Linked to Single Gene Mutations, Hyperactivation of Complement System
GenomeDx Prostate Cancer Tests Get New York State Approval

The Scan

More Reproducible

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

To Catch the Swap

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

This Week in Cell

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

Face of the Suspect

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

Main menu